PPT-Pulmonary Hypertension (PH)

By Ahmad AlMasri Definition defined as mean pulmonary artery pressure of 25 mmHg at rest as measured at right heart catheterisation N ormal mean pulmonary artery pressure . Sheet What I s Pulmonary Hypertension? Pulmonary hypertension occurs when the pressure in the blood vessels leading from the heart to the lungs is too high. The heart pumps blood from the right vent Ya. . Gonna. Call. Pulm. Consults. Lana . Melendres. Pulm. /CC Division. Pulm. . Htn. Program Director. 4/24/13. Objectives. Define pulmonary hypertension (PH. ) and pulmonary arterial hypertension (PAH). Maria Hymon, MSN, ACNP-BC. Definition. Increased blood pressure in the pulmonary artery, veins, or capillaries. Progressive disease leading to Right ventricular failure and eventual death . Right Heart Catheterization Findings. PGYV PULMONARY FELLOW. FINANCIAL DISCLOSURES. None. OBJECTIVES. Learn to define the disorder. Classification and prevalence. Pathophysiology and histopathology. Presentation. Screening and diagnostic methods. Professor of Medicine. Director . Pulmonary . Hypertension Center. Boston University/Boston Medical Center. Boston, Massachusetts. The Health Economics of PAH. Panelists. R. James White, MD, PhD. Associate Professor of Medicine. Rajan Joshi MD,FCCP, FAASM. Assistant Professor, Pulmonary Critical care, Sleep Medicine at UKHC. Medical Director, Pulmonary Rehabilitation, UKHC, Lexington. KY. TLC & Sleep Center-PR, Richmond, KY.      Providing Continuing Education for Healthcare Professionals.      Provided by ProCE, LLC and supported by an educational grant. from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.. Prof Paul A . Corris. Newcastle University. Newcastle Upon Tyne. Pulmonary Hypertension. Which of the following statements are true. A breathless patient with normal LV systolic function and whose RHC results show a mean PAP of 30 mmHg and a PCW of 23 mmHg has pulmonary arterial hypertension. Scleroderma-Spectrum Disorders. Dinesh Khanna, MD. Professor of Medicine,. Division of Rheumatology,. Department of Medicine. Director, Scleroderma Program. University of Michigan Medical Center. Ann Arbor, MI. (CHMP) AGREED BY EFFICACY WORKING PARTYNovember 2008 ADOPTION BY CHMP FOR RELEASE FOR CONSULTATION18 December 2008 ADOPTION BY CHMP 22 October 2009 DATE FOR COMING INTO EFFECT 1 May 2010 EMEA 200 Lancet Respir Med 2016Published Online € Pulmonary hypertension is becoming an increasingly Pulmonary arterial hypertension, especially the idiopathic form, although still a rare disease with an DR. NISHI. Assistant Professor. Department of Pathology. SKMCH, . Muzaffarpur. Pulmonary Diseases . of Vascular Origin. Pulmonary Embolism and Infarction. Pulmonary Hypertension. Diffuse Pulmonary . Hemorrhage. MARAM ABDALJALEEL, MD.. DERMATOPATHOLOGIST AND NEUROPATHOLOGIST. University of Jordan , school of medicine. Pulmonary Embolism, Hemorrhage, and Infarction. Pulmonary Hypertension. Diffuse Alveolar Hemorrhage Syndromes. Khaled Al Oweidat, MD. PE. Introduction . Partial or complete occlusion of a pulmonary arterial branch by blood clot(thrombus or multiple thrombi).. Deep vein thrombosis and PE are different presentations of the same underlying pathophysiological event, venous thromboembolism (VTE)..